Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy

Study ID
NCT00189683

Study type
Interventional

Study phase
Phase 3

Study status
Unknown status

Trial Acronym

Trial Summary

To compare maintenance chemotherapy with Xeloda to control after best response with first line chemotherapy in advanced colorectal cancer. Main endpoint is progression free survival. A total of 300 patients will be included.

More informations

Trial Starting Date

Jan 01,1970

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit